Stryker to Acquire Patient Safety Technologies
Medical device and equipment manufacturer Stryker Corp. will pay about $120 million to acquire Patient Safety Technologies Inc., which sells the bar code-enabled SurgiCount Safety-Sponge System to keep track of towels and sponges used in operations.
Medical device and equipment manufacturer Stryker Corp. will pay about $120 million to acquire Patient Safety Technologies Inc., which sells the bar code-enabled SurgiCount Safety-Sponge System to keep track of towels and sponges used in operations.
The cash transaction values Patient Safety Technologies stock at $2.22 per share. The stock closed on Dec. 30 at $1.48 on the Over-the-Counter Bulletin Board and then closed at $2.20 on Dec. 31 after the deal was announced in the morning. Still, numerous shareholder rights law firms are investigating if the price is too low and soliciting stockholders for a possible law suit. One law firm, San Diego-based Johnson & Weaver LLP, argues the stock traded as high as $2.36 in July 2013 and that an analyst gave it a target price of $2.50.
Patient Safety Technologies CEO Brian Stewart in a statement said the acquisition price delivers significant shareholder value and that Stryker is an established medical device leader that can drive higher growth. The companies expect the acquisition to close in the first quarter.
The cash transaction values Patient Safety Technologies stock at $2.22 per share. The stock closed on Dec. 30 at $1.48 on the Over-the-Counter Bulletin Board and then closed at $2.20 on Dec. 31 after the deal was announced in the morning. Still, numerous shareholder rights law firms are investigating if the price is too low and soliciting stockholders for a possible law suit. One law firm, San Diego-based Johnson & Weaver LLP, argues the stock traded as high as $2.36 in July 2013 and that an analyst gave it a target price of $2.50.
Patient Safety Technologies CEO Brian Stewart in a statement said the acquisition price delivers significant shareholder value and that Stryker is an established medical device leader that can drive higher growth. The companies expect the acquisition to close in the first quarter.
More for you
Loading data for hdm_tax_topic #better-outcomes...